Retrospective Evaluation of Risk Factors and Immunohistochemical Findings for Pre-Neoplastic and Neoplastic lesions of Upper Urinary Tract in Patients with Chronic Nephrolithiasis

  • Desai, Fanny Sharadkumar (Department of Biotechnology, Manipur University) ;
  • Nongthombam, Jitendra (Department of Urology, Jawaharlal Nehru Institute of Medical Sciences) ;
  • Singh, Lisam Shanjukumar (Department of Biotechnology, Manipur University)
  • Published : 2016.01.11


Background: Urinary stones are known predisposing factors for upper urinary tract carcinoma (UUTC) which are commonly detected at advanced stage with poor outcome because of rarity and lack of specific criteria for early detection. Aims and objectives: The main aim was to evaluate the impact of age, gender andstone characteristics on risk of developing UUTC in patients with chronic nephrolithiasis. We also discuss the role of aberrant angiogenesis (AA) and immunohistochemical expression of p53, p16INK4a, CK20 and Ki-67 in diagnosis of pelvicalyceal neoplastic (NL) and pre-neoplastic lesions (PNL) in these patients. Materials and Methods: Retrospective analysis of pelvicalyceal urothelial lesions from 88 nephrectomy specimens were carried out in a tertiary care centre from June 2012 to December 2014. Immunohistochemistry (IHC) was performed on 37 selected cases. Computed image analysis was performed to analyse aberrant angiogenesis. Results: All UUTC (5.7%) and metaplastic lesions were found to be associated with stones. Some 60% were pure squamous cell carcinoma and 40% were transitional cell carcinoma. Odd ratios for developing NL and PNL lesions in presence of renal stone, impacted stones, multiple and large stag horn stones were 9.39 (95% CI 1.15-76.39, p value 0.05), 6.28 (95% CI 1.59-24.85, p value 0.000) and 7.4 (95% CI, 2.29-23.94, p value 0.001) respectively. When patient age was ${\geq}55$, the odds ratio for developing NL was 3.43 (95% CI 1.19-9.88, p value 0.019). IHC analysis showed that mean Ki-67 indices were $3.15{\pm}3.63%$ for non-neoplastic lesions, $10.0{\pm}9.45%$ for PNL and $28.0{\pm}18.4%$ for NL. Sensitivity and specificity of CK20, p53, p16INK4a, AA were 76% and 95.9%; 100% and 27.5%; 100% and 26.5%; 92.3 % and 78.8% respectively. Conclusions: Age ${\geq}55years$, large stag horn stones, multiple stones and impacted stones are found to be associated with increased risk of NL and PNL in UUT. For flat lesions, a panel of markers, Ki 67 index >10 and presence of aberrant angiogenesis were more useful than individual markers.


Upper urinary tract carcinoma;neoplastic lesions;pre-neoplastic lesions;renal stones


  1. Amin M, Epstein J, Ulbright T et al (2014). Best Practices Recommendations in the Application of Immunohistochemistry in Urologic Pathology Report From the International Society of Urological Pathology Consensus Conference. Am J Surg Pathol, 38, 1017-22
  2. Beyer-Boon ME, Cuypers LH, de Voogt HJ, Brussee JA (1978). Cytological changes due to urinary calculi: a consideration of the relationship between calculi and the development of urothelial carcinoma. Br J Urol, 50, 81-9
  3. Chen S, Wu W, Tu H et al (2013). Glutathione S-transferase expression in upper urinary tract urothelial carcinomas: a Taiwan Study Asian Pac J Cancer Prev, 14, 6475-9
  4. Cheungpasitporn W, Thongprayoon C, O'corragain OA et al (2015). The risk of kidney cancer in patients with kidney stones: a systematic review and meta-analysis. QJM: An International Journal of Medicine, 108, 205-12
  5. Cowan NC (2012). CT urography for hematuria. Nat Rev Urol, 13, 218-26.
  6. Deniz K, Kala M (2010). Intestinal Metaplasia of the Renal Pelvis. Urol J, 7, 287-9.
  7. Eble JN, Sauter G, Epstein JI et al (2004). WHO classification of tumours: pathology and genetics of tumours of the urinary system and male genital organs. IARC Press, Lyon, France, 111-2
  8. Epstein J (2010).Diagnosis and Classification of Flat, Papillary, and Invasive Urothelial Carcinoma: The WHO/ISUPConsensus. International Journal of Surgical Pathology, 18, 106-11
  9. Feng Ch, Wang L, Ding G et al (2014). Predictive value of clinicopathological markers for the metachronous bladder cancer and prognosis of upper tract urothelial carcinoma. SCIENTIFIC REPORTS, 4.
  10. Gaisa NT, Braunschweig T, Reimer N et al (2011). Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer. Virchows Arch, 458, 301-12.
  11. Golan S, Nadu A, Lifshitz D (2015). The role of diagnostic ureteroscopy in the era of computed tomography urography. BMC Urology, 15.
  12. Hartmann A, Moser K, Kriegmair M (1999). Frequent Genetic Alterations in Simple Urothelial Hyperplasias of the Bladder in Patients with Papillary Urothelial Carcinoma. The American Journal of Pathology, 154, 721-7
  13. Hong S, Kwon T, You D et al (2014). Incidence of benign results after laparoscopic radical nephroureterectomy. JSLS, 18, 335.
  14. Jain A, Mittal D, Jindal A et al (2011). Incidentally detected squamous cell carcinoma of renal pelvis in patients with staghorn calculi: case series with review of the literature. ISRN Oncol.
  15. Katz R, Gofrit ON, Golijanin D et al (2005). Urothelial cancer of the renal pelvis in percutaneous nephrolithotomy patients. Urol Int, 75,17-20
  16. Kim M, Chung J, Hwang I et al ( 2009). Stag horn Stones Combined with Transitional Cell Carcinoma of the Renal Pelvis. Korean Journal of Urology, 50, 1027-31
  17. Marak A, Shantibala K, Singh A, Singh N, Singh S (2013). Urolithiasis prevalence and related factors in a rural area of Manipur. Int J Med Sci Public Health, 2, 956-9
  18. Messer J, Shariat SF, Brien JC, et al (2011). Urinary cytology has a poor performance for predicting invasive or high grade upper-tract urothelial carcinoma. BJU Int, 108, 701-5
  19. Montironi R, Lopez-Beltran A, Scarpelli M, Mazzucchelli R, Cheng L (2008). Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder. Histopathology, 53, 621-33
  20. Murata Sh, Iseki M, Mitsuru Kinjo M et al (2010). Molecular and Immunohistologic Analyses Cannot Reliably Solve Diagnostic Variation of Flat Intraepithelial Lesions of the Urinary Bladder. Am J Clin Pathol, 134, 862-72
  21. Nagy JA, Chang S-H, Dvorak AM, Dvorak HF (2009). Why are tumour blood vessels abnormal and why is it important to know?. British Journal of Cancer, 100, 865-9
  22. Raghavendran M, Rastogi A, Dubey D, et al (2003). Stones associated renal pelvic malignancies. Indian J Cancer, 40, 108-12
  23. Raphael V, Sailo S, Bhuyan A, Phukan M (2011). Mucinous adenocarcinoma of the renal pelvis with adenocarcinoma in situ of the ureter. Urol Ann, 3, 164-6
  24. Readal N, Epstein JI (2010). Papillary urothelial hyperplasia: relationship to urothelial neoplasms. Pathology, 42, 360-3
  25. Rheaume-Lanoie J, Lepanto L, Fradet V, Billiard JS, Tang A (2014). Diagnostic performance of ultrasound for macroscopic hematuria in the era of multidetector computed tomography urography. Can Assoc Radiol J, 65, 253-9
  26. Roupret M, Babjuk M, Comperat E et al (2013). European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol, 63, 1059-71
  27. Sadow CA, Wheeler SC, Kim J, Ohno-Machado L, Silverman SG (2010). Positive predictive value of CT urography in the evaluation of upper tract urothelial cancer. Am J Roentgenol, 195, 337-43
  28. Sahoo T, Das S, Mishra C, et al (2015). Squamous Cell Carcinoma of Kidney and Its Prognosis: A Case Report and Review of the Literature. Case Rep Urol.
  29. Sasaki Y, Sasaki T, Kawai T et al (2014) HER2 protein over expression and gene amplification in upper urinary tract urothelial carcinoma-an analysis of 171 patients. Int J Clin Exp Pathol, 7, 699-708
  30. Singh PP, Singh LBK, Prasad S, Singh M (1978). Urolithiasis in Manipur (north eastern region of India). Incidence and chemical composition of stones. The American Journal of Clinical Nutrition, 31, 1519-25
  31. Sun LM, Lin CL, Chang YJ et al (2013). Urinary tract stone raises subsequent risk for urinary tract cancer: a population-based cohort study. BJU Int, 112, 1150-5
  32. Sobin LH, Gospodarowicz MK, Wittekind Ch (2009). [Renal Pelvis and ureter] TNM classification of malignant tumours. Urological tumours. International Union Against Cancer. Wiley-Blackwell, New York
  33. Tai Y, Chiang I, Huang Ch, Tai H, Pu Y (2015). Effectiveness of different diagnostic tools for upper urinary tract urothelial carcinoma. Urological Science, 26, 57-60
  34. Vashistha V, Shabsigh A, Zynger D (2013). Utility and diagnostic accuracy of ureteroscopic biopsy in upper tract urothelial carcinoma. Archives of Pathology & Laboratory Medicine, 137, 400-7
  35. Wu X (2009). Biology of urothelial tumorigenesis: insights from genetically engineered mice. Cancer Metastasis Rev, 28, 281-90
  36. Yamany T, van Batavia J, Ahn J, Shapiro E, Gupta M (2015). Ureterorenoscopy for upper tract urothelial carcinoma: how often are we missing lesions?. Urology, 85, 311-5.
  37. Yeh CC, Lin TH, Wu HC et al (2007). A high association of upper urinary tract transitional cell carcinoma with nonfunctioning kidney caused by stone disease in Taiwan. Urol Int, 79, 19-23.
  38. Zengin K, Tanik S, Sener NC et al (2015). Incidence of renal carcinoma in non-functioning kidney due to renal pelvic stone disease. Molecular and Clinical Oncology, 3, 941-3
  39. Zhou H, Huang H, Shapiro E et al (2012).Urothelial tumour initiation requires deregulation of multiple signalling pathways: implications in target-based therapies. Carcinogenesis, 33, 770-80
  40. Zhou W, Zhong K, Wang J et al (2014). Intestinal metaplasia of the renal pelvis: A case report and literature review. ONCOLOGY LETTERS, 8, 2664-8